Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
About Me
Blog Archive
-
▼
2007
(82)
-
▼
April
(24)
- BMS: Unlocking value from late stage compounds
- Rebuffing a Mack Attack
- Doggie Prozac featured on NPR's Morning Edition
- Giles
- Pricing of Pfizer's Maraviroc - Part Two
- Pricing of Pfizer's Maraviroc
- This part of the game is brought to you by...the OIG!
- Amgen's financial engineering backfires
- Going to the Dogs - Part Two
- Pharma industry going to the dogs?
- Virginia Tech
- Pharmalyst merits a mention on ...PharmaGossip!!
- Casodex International Pricing
- Chantix: The making of a quiet blockbuster?
- Pharma Giles: Fresh fruit from rotting vegetables
- International Pharma Pricing: All smoke & mirrors
- Exubera: More ammo to pull the plug?
- About me
- Zelnorm: Statistically insignificant to significant
- Male HPV Market Size
- More evidence of shaky pharma stock research
- Earnings Season & Pfizer's Prospects
- What is Abbott's profit maximization price in Thai...
- Zelnorm: The financial hit and lingering doubts
-
▼
April
(24)
Links
- Brandweek NRx
- Clinical Psyc
- Dr. Peter Rost
- Drug Watcher
- E-Drug Search Blog
- Healthy Skepticism
- In the pipeline
- IN VIVO Blog
- Online Prescriptions
- Pfizer Sales Representative Bill of Rights
- Pharma Marketing Blog
- Pharma's cutting edge
- PharmaFraud
- PharmaGiles
- PharmaGossip
- Pharmalot
- PharmedOut
- Prescription Access Litigation
- Scientific Misconduct
- The numbers guy
- WSJ Health Blog
1 comment:
Life imitating art, I'm sure...
Post a Comment